Ingevity (NYSE: NGVT) reported Q3 EPS of $0.86, $0.10 better than the analyst estimate of $0.76. Revenue for the quarter came in at $264.1 million versus the consensus estimate of $260.88 million.

Company narrows fiscal year 2017 sales guidance to between $945 million and $955 million and narrows and raises adjusted EBITDA guidance to between $227 million and $232 million

For earnings history and earnings-related data on Ingevity (NGVT) click here.